From July 1, 2023 to September 30, 2023, the company has repurchased 861,800 shares, representing 2.36% for ¥2,762.72 million. With this, the company has completed the repurchase of 910,200 shares, representing 2.49% for ¥2,927.18 million under the buyback announced on May 15, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,205 JPY | +0.47% | +1.26% | -1.99% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.99% | 719M | |
+32.81% | 704B | |
+28.59% | 577B | |
-3.83% | 348B | |
+18.25% | 327B | |
+5.38% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.14% | 147B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.